CYBRD1 as a modifier gene that modulates iron phenotype in HFE p.C282Y homozygous patients

Abstract

The online version of this article has a Supplementary Appendix. BackgroundMost patients with hereditary hemochromatosis in the Caucasian population are homozygous for the p.C282Y mutation in the HFE gene. The penetrance and expression of hereditary hemochromatosis differ largely among cases of homozygous p.C282Y. Genetic factors might be involved in addition to environmental factors. Design and MethodsIn the present study, we analyzed 50 candidate genes involved in iron metabolism and evaluated the association between 214 single nucleotide polymorphisms in these genes and three phenotypic outcomes of iron overload (serum ferritin, iron removed and transferrin saturation) in a large group of 296 p.C282Y homozygous Italians. Polymorphisms were tested for genetic association with each single outcome using linear regression models adjusted for age, sex and alcohol consumption. ResultsWe found a series of 17 genetic variants located in different genes with possible additive effects on the studied outcomes. In order to evaluate whether the selected polymorphisms could provide a predictive signature for adverse phenotype, we re-evaluated data by dividing patients in two extreme phenotype classes based on the three phenotypic outcomes. We found that only a small improvement in prediction could be achieved by adding genetic information to clinical data. Among the selected polymorphisms, a significant association was observed between rs3806562, located in the 5'UTR of CYBRD1, and transferrin saturation. This variant belongs to the same haplotype block that contains the CYBRD1 polymorphism rs884409, found to be associated with serum ferritin in another population of p.C282Y homozygotes, and able to modulate promoter activity. A luciferase assay indicated that rs3806562 does not have a significant functional role, suggesting that it is a genetic marker linked to the putative genetic modifier rs884409. ConclusionsWhile our results support the hypothesis that polymorphisms in genes regulating iron metabolism may modulate penetrance of HFE-hereditary hemochromatosis, with emphasis on CYBRD1, they strengthen the notion that none of these polymorphisms alone is a major modifier of the phenotype of hereditary hemochromatosis.Key words: hemochromatosis, SNP, iron, gene, ferritin, transferrin saturation.Citation: Pelucchi S, Mariani R, Calza S, Fracanzani AL, Modignani GL, Bertola F, Busti F, Trombini P, Fraquelli M, Forni GL, Girelli D, Fargion S, Specchia C, and Piperno A. CYBRD1 as a modifier gene that modulates iron phenotype in HFE p. C282Y homozygous patients. Haematologica 2012;97(12):1818-1825. doi:10.3324/haematol.2012 ABSTRACT© F e r r a t a S t o r t i F o u n d a t i o n

Molecular Mediators Governing Iron-Copper Interactions

“…Furthermore, in mice, CYBRD1 was shown to be the only iron-responsive ferrireductase, presumably providing additional ferrous iron for transport by DMT1 to support enhanced iron absorption in response to hypoxia (61), iron deprivation, and pregnancy (13). Interestingly, it was also recently reported that CYBRD1 is a potential modifier of the iron-related phenotype in patients with hereditary hemochromatosis (85). CYBRD1 may thus be necessary to maintain iron homeostasis when demand for dietary iron increases, but it is not absolutely required under basal conditions.…”

Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease

“…Various genetic modifiers have been identified as influencing the clinical expression of haemochromatosis. These include mutations in the HAMP , HFE2 and TFR2 genes and polymorphisms in the BMP2 , BMP4 , CYBRD1 , HP , LTA , MPO , TMPRSS6 and TNF genes (Milet et al 2007; Rochette et al 2010; Valenti et al 2012; Pelucchi et al 2012). In addition, several environmental modifiers (e.g.…”

Proprotein convertase 7 rs236918 associated with liver fibrosis in Italian patients with HFE‐related hemochromatosis

“…During the last 10 years, candidate gene and genome‐wide association studies (GWAS) have been performed to identify rare or common genetic modifiers of iron overload in p.Cys282Tyr homozygotes. However, only few putative genetic modifiers have been identified so far in humans but were not confirmed in a recent GWAS that identified the rs3811647 polymorphism in the transferrin gene as the only single nucleotide polymorphism (SNP) significantly associated with iron metabolism through serum transferrin and iron levels . Recently, we showed that patients diagnosed in latest years have a disease characterized by a milder iron overload, a lower prevalence of cirrhosis and extrahepatic manifestations likely because of a better awareness of the disease by physicians and an easy access to HFE genotyping, leading to an earlier diagnosis.…”